ERBB2 and breast carcinoma: Similarly, in the study by Stevic et al. (2018) significantly higher levels of exosomal miRNA-376c, miRNA-382 and miRNA-433 are observed in TNBC patients, but not in HER2-positive breast cancer patients [121].